Trial NCT04362293

View at ClinicalTrials.gov 
Org. Study IDs: SCDHCT

Last trial update was posted on 2023-08-03

MeSH Interventions

Alemtuzumab Azathioprine Cyclophosphamide Hydroxyurea MTOR Inhibitors Plerixafor Sirolimus Temsirolimus Thiotepa

MeSH Conditions

Anemia, Sickle Cell

Other Conditions

Sickle Cell Disease

Stopping Reasons

We are holding enrollment, due to some recent SAEs.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID